Bliss GVS Pharma Hits Day High with Strong 13.52% Surge

Bliss GVS Pharma, a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 13.52% as of September 30, 2025. The stock reached an intraday high of Rs 154.25, reflecting a 5.07% increase during the trading session. This performance outpaced the sector by 4.62%, marking a notable achievement for the company.

Over the past two days, Bliss GVS Pharma has demonstrated a consecutive gain, accumulating a total return of 6.1%. In terms of moving averages, the stock is currently positioned higher than its 5-day, 20-day, 100-day, and 200-day moving averages, although it remains below the 50-day moving average.

In the broader market context, the BSE Small Cap index is leading with a gain of 0.43%, while the Sensex opened higher at 80,541.77, reflecting a modest gain of 0.22%. Bliss GVS Pharma’s performance over the past year stands out, with a 25.00% increase compared to the Sensex’s decline of 4.59%. This trend highlights the company’s resilience and market position within its industry.